rs12946510 — IKZF3 IKZF3 17q21 FOXO1-enhancer variant

IKZF3 17q21 — The FOXO1-Enhancer Dial Between Asthma and Autoimmunity

At chromosome 17q21 sits one of the most consequential regulatory loci in human immunology — a ~130-kb haploblock containing ORMDL3¹¹ ORMDL3
Orosomucoid-like protein 3; a transmembrane protein anchored in the endoplasmic reticulum that regulates sphingolipid biosynthesis, ICAM-1 expression, and the unfolded protein response, all of which influence airway epithelial responses to viral infection and allergen challenge, GSDMB (gasdermin B), IKZF3 (Aiolos), ZPBP2, and GSDMA. Genetic variants across this locus associate with childhood asthma, allergic rhinitis, multiple sclerosis, inflammatory bowel disease, primary biliary cholangitis, and ankylosing spondylitis — a remarkable span of inflammatory phenotypes controlled by a single regulatory neighbourhood.

rs12946510 at GRCh38 chr17:39,756,124 is an intergenic variant that sits within a chromatin-accessible enhancer element flanking the IKZF3 gene on the distal end of the 17q21 haploblock. It is one of the few 17q21 variants with direct experimental validation of its functional mechanism.

The Mechanism

The C allele at rs12946510 maintains a FOXO1 binding motif²² FOXO1 binding motif
Forkhead box protein O1 (FOXO1) is a transcription factor essential for B cell development, germinal centre reactions, and immune tolerance; it binds DNA at the sequence GTAAACA; the C allele of rs12946510 preserves this sequence while the T allele disrupts it, as well as binding sites for MEF2A and MEF2C (myocyte enhancer factor family members critical for lymphocyte differentiation). The T allele disrupts all three of these transcription factor binding sites, reducing the enhancer's activity and consequently lowering expression of ORMDL3, GSDMB, and IKZF3 in immune cells.

CRISPR/Cas9 editing³³ CRISPR/Cas9 editing
Ustiugova et al. Biochim Biophys Acta Mol Basis Dis 2023; isogenic T helper cell lines bearing CC, CT, or TT genotypes at rs12946510 were created and compared for gene expression and cellular activation profiles provided direct causal proof: cells carrying the T allele showed lower IKZF3 and ORMDL3 expression and reduced cellular activation. This makes rs12946510 one of the few 17q21 variants with experimentally validated functional consequence rather than just statistical association.

The consequence of this expression difference is tissue-context dependent. Higher ORMDL3 in airway epithelial cells increases ICAM-1 expression (the rhinovirus receptor), amplifies the unfolded protein response, and elevates sphingolipid signalling, collectively priming the airway for exaggerated inflammatory responses to viral and allergen challenge. By contrast, IKZF3/Aiolos normally suppresses germinal centre hyperactivation and IgE overproduction — the T allele's lower IKZF3 expression removes this brake on B cell responses, which may underlie its association with autoimmune conditions where excessive immune activation is the pathological driver.

The Evidence

The GABRIEL consortium GWAS⁴⁴ GABRIEL consortium GWAS
Moffatt et al. NEJM 2010; 10,365 asthma cases and 16,110 controls across 10 European populations; genome-wide significant signals at the 17q21 locus including the IKZF3/ORMDL3 region established the 17q21 haploblock as the most replicated childhood asthma susceptibility locus, with variants across this region — including the IKZF3 regulatory position at rs12946510 — consistently associated with asthma risk. CRISPR/Cas9 functional validation subsequently confirmed that T allele carriers at rs12946510 have lower ORMDL3 and IKZF3 expression, providing the mechanistic basis for reduced asthma susceptibility.

The systematic analysis of functional SNPs in 17q12-21⁵⁵ systematic analysis of functional SNPs in 17q12-21
Ustiugova et al. Genes 2019; bioinformatic prediction of transcription factor binding across all 17q21 SNPs; reporter assays in three cell types; rs12946510 had the strongest functional prediction of any variant tested identified rs12946510 as the variant with the greatest predicted impact on transcription factor binding in the entire 17q21 locus — with over 20-fold changes in MEF2A, MEF2C, FOXO1, SOX3, and SOX6 binding affinity. The primary biliary cholangitis study⁶⁶ primary biliary cholangitis study
Hitomi et al. Sci Rep 2017; eQTL analyses of rs12946510 in whole blood and spleen; T allele significantly associated with lower ORMDL3 and GSDMB expression confirmed that the T allele's functional consequences are detectable in blood at the level of gene expression.

For multiple sclerosis, RRMS patients from Serbia⁷⁷ RRMS patients from Serbia
Stefanovic et al. J Neuroimmunol 2020; TT genotype nominal MS association; decreased ORMDL3 and GSDMB mRNA levels in TT homozygotes vs non-TT patients demonstrated the inverse phenotype: when the FOXO1 binding site is disrupted (T allele), reduced IKZF3/Aiolos expression may impair normal regulatory brake on B cell activation, predisposing to autoimmune demyelination.

Practical Implications

CC homozygotes carry both copies of the FOXO1-binding, higher-expression haplotype — the configuration associated with increased ORMDL3/GSDMB-driven airway inflammation and the highest asthma susceptibility at this locus. This variant is most clinically relevant for childhood-onset asthma and virus-triggered wheeze, where ORMDL3's role in ICAM-1 expression amplifies rhinovirus susceptibility. Tracking pulmonary function objectively during respiratory viral infections and high-allergen seasons is the highest-yield monitoring action for CC carriers.

TT homozygotes, while protected at this locus from atopic airway disease, carry the FOXO1 binding-disrupted haplotype and the consequent lower IKZF3/Aiolos expression — positioning them at the autoimmune end of the 17q21 spectrum (MS, IBD, PBC associations).

Interactions

rs12946510 operates within the same 17q21 haploblock as rs12936231 (the strongest ORMDL3 eQTL in blood), rs7216389 (the canonical childhood asthma GWAS hit), and rs2872507 (IKZF3 autoimmune variant). These variants are partly correlated but represent distinct functional positions within the 130-kb regulatory region. Carriers of risk haplotypes at multiple 17q21 positions face additive ORMDL3 expression burden, amplifying airway inflammatory priming beyond any single variant alone.

rs2872507 (IKZF3, chr17:39,884,510) is the 17q21 variant most studied for autoimmune associations — its A allele is a risk factor for rheumatoid arthritis and Crohn's disease. Individuals carrying both rs12946510-CC and rs2872507-AA represent the highest-ORMDL3, highest asthma-risk haplotype configuration at 17q21, while those carrying T alleles at rs12946510 alongside autoimmune-risk alleles at rs2872507 may face the autoimmune end of the 17q21 disease spectrum.